Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study

J.T. Nielen, F. de Vries, P.C. Dagnelie, B.J. van den Bemt, P.J. Emans, A. Lalmohamed, A. de Boer, A.E. Boonen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

AimsOsteoarthritis (OA) is the most common musculoskeletal condition in the elderly population. However, no disease modifying drug exists for this disease. In vivo animal studies have suggested that thiazolidinediones (TZD) may be used as disease modifying osteoarthritis drugs (DMOADs). To our knowledge, this has not yet been examined in humans before. The aim was to determine the risk of total joint replacement (TJR) in patients using TZDs compared with diabetic patients using other antidiabetic drugs.

MethodsA population based case-control study was performed using the Clinical Practice Research Datalink (CPRD). Cases (n=94609) were defined as patients >18years of age who had undergone total knee (TKR) or hip replacement (THR) between 2000 and 2012. Controls were matched by age, gender and practice/surgery. Conditional logistic regression analyses were used to estimate the risk of TKR and THR with the use of TZDs in patients currently using one or more antidiabetic drugs. In order to determine effect with prolonged use, we also stratified TZD users by total number of prescriptions prior to surgery. We statistically adjusted our analyses for lifestyle factory, comorbidities and concomitant drug use.

ResultsThere was no difference in risk of TKR (OR 1.09, 95% CI 0.93, 1.27) and THR (OR 0.92, 95% CI 0.76, 1.10) when TZD users were compared with other AD users. Furthermore, we did not find an association with prolonged use of TZDs and TJR.

ConclusionDespite promising results from animal in vivo studies, this study did not find any evidence for a disease modifying osteoarthritic effect of TZDs.

Original languageEnglish
Pages (from-to)370-378
Number of pages9
JournalBritish Journal of Clinical Pharmacology
Volume81
Issue number2
Early online date16 Sep 2015
DOIs
Publication statusPublished - Feb 2016

Keywords

  • arthroplasty
  • diabetes mellitus
  • glitazones
  • osteoarthritis
  • thiazolidinediones
  • RECEPTOR-GAMMA AGONIST
  • NITRIC-OXIDE SYNTHASE
  • EXPERIMENTAL OSTEOARTHRITIS
  • INTRAARTICULAR INJECTIONS
  • ALPHA(2)DELTA LIGAND
  • GENE-EXPRESSION
  • CARTILAGE
  • PIOGLITAZONE
  • CHONDROCYTES
  • ASSOCIATION

Cite this